Stay updated on Vilazodone Safety in GAD: Clinical Trial
Sign up to get notified when there's something new on the Vilazodone Safety in GAD: Clinical Trial page.

Latest updates to the Vilazodone Safety in GAD: Clinical Trial page
- Check3 days agoChange DetectedA site-wide government funding notice has been added, noting that the NIH Clinical Center is open and directing users to cc.nih.gov, and the page shows a new revision tag (v3.4.1) replacing v3.4.0.SummaryDifference0.3%

- Check10 days agoChange DetectedAdditions: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0; Deletions: Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedAdded a Locations section with study sites by state and updated to Revision: v3.3.3.SummaryDifference1%

- Check67 days agoChange DetectedRevision: v3.3.2 replaces the previous v3.3.1 on the page.SummaryDifference0.0%

- Check74 days agoChange DetectedPublication section wording updated to 'automatically filled in from PubMed' (instead of 'come from PubMed'), and the revision label changed from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Vilazodone Safety in GAD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vilazodone Safety in GAD: Clinical Trial page.